Amarin Pharma, Inc. et al v. Roxane Laboratories, Inc. et.al,

Filing 177

ORDER - The Court GRANTS the parties' stipulation (ECF No. 176 ). The expert disclosure deadline is extended to January 14, 2019. Additionally, the Court SETS a telephonic hearing on Defendants' motion to modify the discover y plan and scheduling order (ECF No. 165 ) on January 14, 2019, at 2:00 p.m. The parties shall call the Court conference line at 877-402-9757 at least five minutes prior to the hearing. The conference code is 6791056. Signed by Magistrate Judge Nancy J. Koppe on 1/9/2019. (Copies have been distributed pursuant to the NEF - DRM)

1
2
3
4
5
UNITED STATES DISTRICT COURT
6
DISTRICT OF NEVADA
7
8
AMARIN PHARMA, INC., et al.,

Case No.: 2:16-cv-2525-MMD-NJK

9
Plaintiff(s),

Order

10
v.

(Docket No. 176)

11
12
13
14

WEST-WARD PHARMACEUTICALS
CORP.,
Defendant(s).
Pending before the Court is the parties’ stipulation requesting an extension of the deadline

15 to serve initial expert reports. Docket No. 176. The parties additionally request a telephonic
16 hearing on Defendants’ emergency motion to modify the scheduling order. Id. at 2. See also
17 Docket No. 165.
18

The Court GRANTS the parties’ stipulation. Docket No. 176. The expert disclosure

19 deadline is extended to January 14, 2019. Additionally, the Court SETS a telephonic hearing on
20 Defendants’ motion to modify the discovery plan and scheduling order on January 14, 2019, at
21 2:00 p.m. The parties shall call the Court conference line at 877-402-9757 at least five minutes
22 prior to the hearing. The conference code is 6791056. In order to ensure a clear recording of the
23 hearing, the calls must be made using a land line phone. Cell phone calls, as well as the use of a
24 speaker phone, are prohibited.
25

IT IS SO ORDERED.

26

Dated: January 9, 2019

27

______________________________
NANCY J. KOPPE
United States Magistrate Judge

28
1